Norwegian patient export to Germany booming:
This article was originally published in Clinica
Executive Summary
The number of patients travelling from Norway to the north German state of Schleswig-Holstein is on the increase, the regional hospitals' association (KGSH) announced last week in Kiel. The patient treatment agreement between the Norwegian and German governments (see Clinica No 943, p 7) has already seen 100 Norwegian citizens treated in Schleswig-Holstein and this number is set to double by the end of the year. The success of the initiative has prompted Norway to enter into negotiations with more of the state's clinics Norway set aside NKr1 billion ($110 million) to finance the scheme. Whether more money will be released by state health insurers to finance an extension of the scheme has not yet been decided.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.